Scheme optimization of acupoints compatibility and influence factors of the effect

Lijuan Ha, Xiaona Liu, Yanze Liu, Mujun Zhi, Hailin Jiang, Jingying Zhao, Yiming Wang, Xiaoru Xu, Le Guo, Jiazhen Cao, Liyuan Chen, Yue Yuan, Tie Li, Fuchun Wang, Lijuan Ha, Xiaona Liu, Yanze Liu, Mujun Zhi, Hailin Jiang, Jingying Zhao, Yiming Wang, Xiaoru Xu, Le Guo, Jiazhen Cao, Liyuan Chen, Yue Yuan, Tie Li, Fuchun Wang

Abstract

Background: Acupuncture may be a clinically effective treatment for insomnia. We will perform a multicenter, large-scale, single-blinded, randomized controlled trial to compare the differences in the clinical efficacy between the use of singleacupoints and compatibilityacupoints in the treatment of primary insomnia.

Methods/design: A total of 333 participants will be randomly assigned to 2 acupoint treatment groups or 1 nonacupoint control group in a 1:1:1 ratio by a central stochastic system. The acupuncture groups are: the single acupoint group: Shenmen (HT7); and he compatibility acupoint group: Shenmen (HT7), Baihui (DU20), and Sanyinjiao (SP6). The observation period of this trial will be 10 weeks. All patients will be followed for 1 week before randomization (baseline phase). After randomization, the patients will receive 30 minutes of electro-acupuncture once per day for 5 weeks. In the fourth week after the treatment, follow-up will be performed once. The primary outcome will be the Pittsburgh sleep quality index score at 1 week before randomization and 2 and 8 weeks after randomization. The secondary outcomes will include data from sleep diaries, Athens insomnia scale scores, ShortForm-36 Health Survey scores, electroencephalogram technology results and polysomnogram) results. Patients will be required to complete a sleep diary every day during the treatment period. Patients will also undergo electroencephalogram technology and polysomnogram 1 week before randomization and 5 weeks after randomization. The other secondary outcomes will be measured 1 week before randomization and 5 and 9 weeks after randomization.

Discussion: This trial will be helpful in identifying whether acupuncture at compatibility acupoints is more effective than acupuncture at single acupoints.

Trial registration: Clinical Trials.govNCT02448602, Registered 5May 2015, https://www.clinicaltrials.gov/ct2/show/NCT02448602?term=NCT02448602&rank=1.

Conflict of interest statement

The authors report no conflicts of interest.

Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

References

    1. Buysse DJ, Rush AJ, Reynolds CF. Clinical management of insomnia disorder. JAMA 2017;318:1973–4.
    1. Ohayon MM, Reynolds CF. Epidemiological and clinical relevance of insomnia diagnosis algorithms according to the DSM-IV and the International Classification of Sleep Disorders (ICSD). Sleep Med 2009;10:952–60.
    1. Morin CM, LeBlanc M, Belanger L, Ivers H, Merette C, Savard J. Prevalence of insomnia and its treatment in Canada. Can J Psychiatry 2011;56:540–8.
    1. Morin CM, Benca R. Chronic insomnia. Lancet 2012;379:1129–41.
    1. Morin CM, LeBlanc M, Daley M, Gregoire JP, Merette C. Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med 2006;7:123–30.
    1. Kalejaiye O, Raheem AA, Moubasher A, Capece M, McNeillis S, Muneer A, et al. Sleep disorders in patients with erectile dysfunction. BJU Int 2017;120:855–60.
    1. Adamo D, Sardella A, Varoni E, Lajolo C, Biasotto M, Ottaviani G, et al. The association between burning mouth syndrome and sleep disturbance: a case-control multicentre study. Oral Dis 2018;24:638–49.
    1. Jackowska M, Poole L. Sleep problems, short sleep and a combination of both increase the risk of depressive symptoms in older people: a 6-year follow-up investigation from the english longitudinal study of ageing. Sleep Med 2017;37:60–5.
    1. Cepuch G, Gniadek A, Gustyn A, Tomaszek L. Emotional states and sleep disorders in adolescent and young adult cystic fibrosis patients. Folia Med Cracov 2017;57:27–40.
    1. Bouchoucha M, Mary F, Bon C, Bejou B, Airinei G, Benamouzig R. Sleep quality and functional gastrointestinal disorders. A psychological issue. J Dig Dis 2018;19:84–92.
    1. Porter J. Guided fantasy as a treatment for childhood insomnia. Aust N Z J Psychiatry 1975;9:169–72.
    1. Pimentel D, Donlea JM, Talbot CB, Song SM, Thurston AJF, Miesenböck G. Operation of a homeostatic sleep switch. Nature 2016;536:333.
    1. Dong L, Soehner AM, Belanger L, Morin CM, Harvey AG. Treatment agreement, adherence, and outcome in cognitive behavioral treatments for insomnia. J Consult Clin Psychol 2018;86:294–9.
    1. Chung KF, Yeung WF, Yu BY, Leung FC, Zhang SP, Zhang ZJ, et al. Acupuncture with or without combined auricular acupuncture for insomnia: a randomised, waitlist-controlled trial. Acupunct Med 2018;36:02–13.
    1. Tfelt-Hansen P, Block G, Dahlof C, Diener HC, Ferrari MD, Goadsby PJ, et al. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia 2000;20:765–86.
    1. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193–213.
    1. Popevic MB, Milovanovic APS, Milovanovic S, Nagorni-Obradovic L, Nesic D, Velaga M. Reliability and validity of the Pittsburgh sleep quality index-serbian translation. Eval Health Prof 2018;41:67–81.
    1. Buchanan DT, McCurry SM, Eilers K, Applin S, Williams ET, Voss JG. Brief behavioral treatment for insomnia in persons living with HIV. Behav Sleep Med 2018;16:244–58.
    1. Bottcher B, Fessler S, Friedl F, Toth B, Walter MH, Wildt L, et al. Health-related quality of life in patients with polycystic ovary syndrome: validation of the German PCOSQ-G. Arch Gynecol Obstet 2018;297:1027–35.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe